PEG GCSF and GCSF (Granulocyte Colony Stimulating Factor) effects on neutropenia after chemotherapy in breast cancer

Not Applicable

• Conditions: Breast cancer.; Malignant neoplasm of breast; C50-C50

• Registration Number: IRCT201604248397N4
• Lead Sponsor: Vice Chancellor for Research of Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

age older than 15 years and younger than 70; no history of prior cancer and chemotherapy; now has breat cancer only. Exclusion criteria: age below 15 and older than 70; other blood malignancies or history of cancer; history of prior chemotherapy.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
White blood cells level. Timepoint: before intervention, first week, second week and third week after chemotherapy. Method of measurement: Laboratory testing.

Secondary Outcome Measures

Name	Time	Method
Bone pain. Timepoint: From the time of ampulla injection till three weeks after. Method of measurement: History taking, pain scale questionaire.